The UBT has been widely used as a test after H. pylori eradication therapy to judge whether the therapy has been successful, [6,16] and the high sensitivity and specificity of the IRUT indicates ...
J Gastroenterol Hepatol. 2005;20(2):270-274. In conclusion, the 13 C-UBT is a reliable and reproducible determinant of H. pylori infection and of the severity of associated gastritis, and it has ...
The global helicobacter pylori diagnostics market revenue was around US$ 581.9 million in 2023 and is estimated to reach US$ 926.3 million by 2032, growing at a compound annual growth rate (CAGR) of 5 ...
Lee and colleagues hypothesized going into the research that their analysis would determine if screening by way of an H. pylori stool antigen test, HPSA, along with a fecal immunochemical test ...